Drug intelligence / Profile preview

magnoflorine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Magnoflorine is a quaternary isoquinoline alkaloid widely distributed in various medicinal plants, including *Magnolia officinalis*, *Phellodendron amurense*, *Tinospora cordifolia*, and *Corydalis* species. It exhibits a broad spectrum of pharmacological activities, including anti-inflammatory, antioxidant, neuroprotective, and anti-tumor effects. Mechanistically, magnoflorine has been shown to inhibit the NF-κB and MAPK signaling pathways, suppress ALOX15-mediated ferroptosis, and activate the PI3K/AKT pathway. It is currently being investigated in preclinical models for its potential therapeutic applications in osteoarthritis, cerebral ischemia-reperfusion injury (stroke), coronary heart disease, and exercise-induced fatigue. Additionally, it has shown promise in remodeling lipid metabolism in the tumor microenvironment of prostate cancer.

Other names
(S)-magnoflorinealpha-magnoflorineMagnoflorine
02

Targets

15-LOX (Lysyl Oxidase)

Beyond the preview

Go deeper on magnoflorine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnoflorine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call